4//SEC Filing
Vellanki Avanish 4
Accession 0001104659-23-023386
CIK 0001724979other
Filed
Feb 16, 7:00 PM ET
Accepted
Feb 17, 6:15 PM ET
Size
5.6 KB
Accession
0001104659-23-023386
Insider Transaction Report
Form 4
Vellanki Avanish
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2023-02-15+318,600→ 318,600 totalExercise: $9.30Exp: 2033-02-15→ Common Stock (318,600 underlying)
Footnotes (1)
- [F1]This option represents a right to purchase a total of 318,600 shares of the Issuer's common stock, one quarter of which will vest on February 15, 2024, with the remaining three quarters vesting in equal monthly installments through February 15, 2027, subject to the Reporting Person's continued service to the Issuer.
Documents
Issuer
Rain Oncology Inc.
CIK 0001724979
Entity typeother
Related Parties
1- filerCIK 0001856682
Filing Metadata
- Form type
- 4
- Filed
- Feb 16, 7:00 PM ET
- Accepted
- Feb 17, 6:15 PM ET
- Size
- 5.6 KB